BK asthma sufferers face FDA-induced sticker shock

FLATBUSH - An FDA-madated change has left some Brooklyn asthma sufferers gasping for breath from sticker shock.

The FDA has ordered manufacturers to phase out chlorofluorocarbon (CFC) inhalers by December 31, 2008. CFC inhalers contain a propellant that allows the medication to quickly reach the lungs, but it also depletes the ozone. Drug companies are switching to environmentally friendly hydrofluoroalkane (HFA) inhalers ahead of time.

Although just as effective, the new inhalers cost more. "The generic albuterol would have cost them $13 to $17 and the new ones ... $30 to $45," says pharmacist Shanel Sattar.

Agnes Greene, who relies on her CFC inhaler daily, was stunned by the change. "I came to get my prescription filled and I found out it's no longer accepted," said Greene.

Health professionals fear patients will try to make their inhalers last to save money instead of using them, putting lives at risk.

Related information:American Lung Association

advertisement | advertise on News 12

Trending Video

1 Neighborhood Brief for April 30
More than 2,000 people took part in the 2 Thousands attend NYPD Cares 5K for kids with disabilities
More than 200 Brooklyn residents received a goody 3 Expecting moms attend massive baby shower in E. Flatbush
A 3-year-old girl died after a car accident 4 3-year-old killed in crash on Bruckner Boulevard
The victim, a man in his 20s, was 5 Man shot in head during Williamsburg drive-by shooting

advertisement | advertise on News 12

Features

Sorry to interrupt...

Your first 5 are free

Access to News12 is free for Optimum, Comcast®, Time Warner® and Service Electric℠ video customers.

Please enjoy 5 complimentary views to articles, photos, and videos during the next 30 days.

LOGIN SUBSCRIBE